Home

Market Capitalization of Senores Pharmaceuticals Ltd

Image

Senores Pharmaceuticals Ltd

NSE: SENORES

Market Cap

₹ 2460.64 crore

Last updated on: Feb 04, 2025

Key Highlights

  • The Market Cap of Senores Pharmaceuticals Ltd is ₹ 2460 crore as of 04 Feb 25 .
  • The Latest Trading Price of Senores Pharmaceuticals Ltd is ₹ 545.3 as of 05 Feb 15:05 .
Image

Senores Pharmaceuticals Ltd

NSE: SENORES

Share Price

₹ 545.3

11.00 (2.06%)

stock direction

Last updated on: Feb 05, 2025

Market Price of Senores Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Senores Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Feb 2025534.3
03 Feb 2025511.7
01 Feb 2025535.05
31 Jan 2025549.1
30 Jan 2025539.15
29 Jan 2025513.75
28 Jan 2025502.55
27 Jan 2025507.65
24 Jan 2025560.7
23 Jan 2025543.3

BlinkX Score for Senores Pharmaceuticals Ltd

Asset Value vs Market Value of Senores Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Senores Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Senores Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Senores Pharmaceuticals Ltd

  • Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
  • Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
  • The Regulated Markets business is focused on Regulated Markets of US and Canada.
  • The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.

Senores Pharmaceuticals Ltd News Hub

Senores Pharma spurts as PAT jumps to Rs 16 cr in Q3 FY25

Profit before tax stood at Rs 20.48 crore in the December 2024 quarter, up 99.61% from Rs 10.26 cror

Read more

23 Jan 25

Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets

Metoprolol Tartrate and Hydrochlorothiazide Tablet is the combination tablet of metoprolol tartrate,

Read more

10 Jan 25

Senores Pharmaceuticals IPO subscribed 93.41 times

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,72,30,918 shares as a

Read more

24 Dec 24

Senores Pharmaceuticals receives USFDA approval for Metoprolol Tartrate and Hydrochlorothiazide Tablet

Senores Pharmaceuticals has received final approval from the United States Food and Drug Administrat

Read more

10 Jan 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Senores Pharmaceuticals Ltd Market Cap

What is the market cap of Senores Pharmaceuticals Ltd?

As of February 5, 2025, Senores Pharmaceuticals Ltd has a market capitalization of ₹2460.64, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Senores Pharmaceuticals Ltd's market capitalization?

Senores Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Senores Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Senores Pharmaceuticals Ltd's market capitalization change?

Senores Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions